Motley Fool Wealth Management LLC Makes New $5.16 Million Investment in Shockwave Medical, Inc. (NASDAQ:SWAV)

Motley Fool Wealth Management LLC bought a new position in shares of Shockwave Medical, Inc. (NASDAQ:SWAV) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 27,083 shares of the company’s stock, valued at approximately $5,164,000. Motley Fool Wealth Management LLC owned 0.07% of Shockwave Medical at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in SWAV. Lindbrook Capital LLC lifted its holdings in shares of Shockwave Medical by 64.8% in the third quarter. Lindbrook Capital LLC now owns 150 shares of the company’s stock worth $30,000 after buying an additional 59 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Shockwave Medical by 297.4% in the third quarter. EverSource Wealth Advisors LLC now owns 155 shares of the company’s stock worth $31,000 after buying an additional 116 shares in the last quarter. Asset Management One Co. Ltd. purchased a new position in shares of Shockwave Medical in the fourth quarter worth $34,000. Operose Advisors LLC purchased a new position in shares of Shockwave Medical in the third quarter worth $49,000. Finally, Venturi Wealth Management LLC purchased a new position in shares of Shockwave Medical in the third quarter worth $82,000. Institutional investors own 95.35% of the company’s stock.

Insider Transactions at Shockwave Medical

In other news, Director Laura Francis sold 1,500 shares of the company’s stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $300.00, for a total value of $450,000.00. Following the transaction, the director now directly owns 3,551 shares in the company, valued at $1,065,300. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, Director Laura Francis sold 1,500 shares of the company’s stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $300.00, for a total value of $450,000.00. Following the completion of the sale, the director now directly owns 3,551 shares of the company’s stock, valued at $1,065,300. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Isaac Zacharias sold 4,000 shares of the company’s stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $287.67, for a total transaction of $1,150,680.00. Following the completion of the sale, the insider now directly owns 56,818 shares of the company’s stock, valued at $16,344,834.06. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 89,813 shares of company stock worth $22,863,919. Insiders own 3.40% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Canaccord Genuity Group reissued a “hold” rating and issued a $335.00 target price (up previously from $263.00) on shares of Shockwave Medical in a report on Friday, April 5th. Wells Fargo & Company upped their price target on shares of Shockwave Medical from $200.00 to $210.00 and gave the company an “equal weight” rating in a research note on Friday, February 16th. Piper Sandler upped their price target on shares of Shockwave Medical from $290.00 to $360.00 and gave the company an “overweight” rating in a research note on Tuesday, April 2nd. SVB Leerink reaffirmed a “market perform” rating and set a $335.00 price target (down previously from $361.00) on shares of Shockwave Medical in a research note on Monday, April 8th. Finally, Wolfe Research reaffirmed a “peer perform” rating on shares of Shockwave Medical in a research note on Friday, April 5th. Ten equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $309.11.

Shockwave Medical Trading Up 0.3 %

SWAV stock traded up $1.01 during mid-day trading on Friday, reaching $330.00. 575,689 shares of the stock traded hands, compared to its average volume of 2,009,896. The company has a debt-to-equity ratio of 1.09, a quick ratio of 10.73 and a current ratio of 11.76. Shockwave Medical, Inc. has a one year low of $157.00 and a one year high of $331.58. The stock has a market capitalization of $12.34 billion, a PE ratio of 85.27, a PEG ratio of 2.44 and a beta of 0.92. The business has a 50-day moving average price of $294.88 and a two-hundred day moving average price of $233.25.

Shockwave Medical (NASDAQ:SWAV) last posted its quarterly earnings results on Thursday, February 15th. The company reported $1.16 EPS for the quarter, topping analysts’ consensus estimates of $0.92 by $0.24. The firm had revenue of $202.98 million for the quarter, compared to analysts’ expectations of $199.43 million. Shockwave Medical had a net margin of 20.17% and a return on equity of 23.97%. The business’s revenue for the quarter was up 41.0% on a year-over-year basis. During the same period in the prior year, the business posted $3.71 earnings per share. Equities research analysts expect that Shockwave Medical, Inc. will post 4.94 EPS for the current year.

Shockwave Medical Company Profile

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.